Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+48.5%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+48.5%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
7.2x
Strong expansion
Streak
3 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 418.63% |
| 2024 | 218.06% |
| 2023 | 63.11% |
| 2022 | -344.54% |
| 2021 | 56.87% |
| 2020 | 58.07% |
| 2019 | 4.94% |
| 2018 | 8.71% |
| 2017 | -14.16% |
| 2016 | -34.78% |